Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum
This study is ongoing, but not recruiting participants.
Study NCT00002811 Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999 Last Updated: July 23, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Precancerous/Nonmalignant Condition
Additional conditions recognized in this trial
Ichthyosis
Keratosis
Precancerous Conditions
Xeroderma Pigmentosum
More general conditions related to this trial
Congenital Abnormalities
DNA Repair-Deficiency Disorders
Genetic Diseases, Inborn
Infant, Newborn, Diseases
Metabolic Diseases
Neoplasms
Photosensitivity Disorders
Pigmentation Disorders
Skin Abnormalities
Skin Diseases
Skin Diseases, Genetic
Interventions listed in this trial
T4N5 liposomal lotion
Additional drug interventions recognized in this trial
Tranilast
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Allergic Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Hematologic Agents
Histamine Agents
Histamine Antagonists
Histamine H1 Antagonists
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Applied Genetics
Back to top of Main Content
